Characterization and promoter identification of metastasis associated protein 1 in human colorectal carcinoma cell lines

Download
2014
Tunçay Çağatay, Seda
Metastasis associated protein 1 (MTA1) is a member of the nuclear remodeling and histone deacetylase (NuRD) complex, which is known to repress the expression of several tumor suppressor genes and has been widely linked to tumor metastasis. 15-lipoxygenase-1 (15-LOX-1) is a lipid metabolizing enzyme that has tumor suppressive properties and is silenced by the NuRD complex in colorectal cancer (CRC). We have previously shown that reexpression of 15-LOX-1 inhibited metastasis in CRC, inhibited the inflammatory transcription factor nuclear factor kappa B (NF-κB) and resulted in reduced expression of MTA1 indicating the presence of a cross talk. In this study, we have first investigated the role of MTA1 in CRC. For this, the gene was silenced and overexpressed in the CRC cell line HCT-116. MTA1 overexpression enhanced metastasis and epithelial mesenchymal transition (EMT) like characteristics of the cells while silencing of MTA1 resulted in reversal of these features.Reexpression of 15-LOX-1 in CRC cell lines HT-29 and LoVo resulted in decreased expression of MTA1. This was due to a decrease in the nuclear levels and the recruitment of p65 to its binding motifs on the MTA1 promoter as well as inhibition of transcriptional activity of NF-κB. As a conclusion, this study not only shows the protumorigenic properties of MTA1 in CRC but also identifies a novel regulatory mechanism by 15-LOX-1 thereby providing a rationale for the development of anti-metastatic intervention strategies targeting MTA1 or 15-LOX-1 expressions.

Suggestions

Investigation of a mechanistic link between 15-Lipoxygenase-1 (15-LOX-1) and Metastasis Associated Protein 1 (MTA1) in human colorectal carcinoma cell lines
ÇAĞATAY, SİBEL; Banerjee, Sreeparna (2013-09-01)
Background: Metastasis Associated Protein 1 (MTA1) is a member of the nuclear remodeling and histone deacetylase (NuRD) complex that is known to repress the expression of several tumor suppressor genes. 15-lipoxygenase-1 (15-LOX-1), a member of the inflammatory eicosanoid pathway, has been shown by us and others to have an anti-tumorigenic role in colon cancer. ALOX15 was recently shown to be repressed by the NuRD complex. Previously we have reported that ectopic expression of 15-LOX-1 in colon cancer cells...
Enrichment of MCF7 breast cancer cells from leukocytes through continuous flow dielectrophoresis
Çağlayan, Zeynep; Külah, Haluk; Department of Electrical and Electronics Engineering (2018)
Circulating tumor cells (CTCs) are cancerous cells detached from a primary tumor site and enter the bloodstream, causing the development of new tumors in a secondary site. Therefore, their detection in blood is critical to assess the metastatic progression and to guide the line of the therapy. However, the rarity of CTCs in the bloodstream and the lack of suitable detection tool hinders their use as a biomarker in malignancies. Recent advances in microfluidic technologies enabled development of point-of-car...
Investigation of the molecular pathways involved in intestinal epithelial differentiation
Sade Memişoğlu, Aslı; Banerjee, Sreeparna; Department of Biology (2014)
The molecular mechanisms of balanced and continuous generation of intestinal epithelial cells, is poorly understood and disruption of this balance may result in neoplastic transformation and malignant growth. Differentiation is regulated by numerous signals, which in turn regulate signaling pathways directing activation or inactivation of certain transcription factors. Perturbations like changes in Ca2+ levels, glucose or amino acid starvation result in an ER stress response, which is also implicated in the...
Synthesis of poly (dl-lactic-co-glycolic acid) coated magnetic nanoparticles for anti-cancer drug delivery
Tansık, Gülistan; Gündüz, Ufuk; Department of Biology (2012)
One of the main problems of current cancer chemotherapy is the lack of selectivity of anti-cancer drugs to tumor cells which leads to systemic toxicity and adverse side effects. In order to overcome these limitations, researches on controlled drug delivery systems have gained much attention. Nanoscale based drug delivery systems provide tumor targeting. Among many types of nanocarriers, superparamagnetic nanoparticles with their biocompatible polymer coatings can be targeted to an intented site by an extern...
Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC Mutagenesis
Petljak, Mia; et. al. (2019-03-01)
Multiple signatures of somatic mutations have been identified in cancer genomes. Exome sequences of 1,001 human cancer cell lines and 577 xenografts revealed most common mutational signatures, indicating past activity of the underlying processes, usually in appropriate cancer types. To investigate ongoing patterns of mutational-signature generation, cell lines were cultured for extended periods and subsequently DNA sequenced. Signatures of discontinued exposures, including tobacco smoke and ultraviolet ligh...
Citation Formats
S. Tunçay Çağatay, “Characterization and promoter identification of metastasis associated protein 1 in human colorectal carcinoma cell lines,” Ph.D. - Doctoral Program, Middle East Technical University, 2014.